Reclassifying Infusion Therapy Space at the University of Arizona

Abstract

This case study focused on reclassifying infusion therapy space at the University of Arizona Medical Center to a physician-based treatment setting. The study followed the managerial decision-making process as it described how the space reclassification was recommended, adopted, and implemented. A successful reclassification required close attention to organizational structure, administrative policies and responsibilities, and related work-flow processes.

Creating genetics-based infusion centers: a case study of two models

“…[1][2][3] The WI group developed their center primarily for adult LSD patients, including uninsured patients and those with Medicare and Medicaid. The center projected that it would have eight initial infusion patients.…”

“…The center includes three medical geneticists and three genetic counselors in an academic setting. Individuals from Wisconsin (WI) and neighboring Michigan and Illinois comprise the patient population of 71, which includes individuals with the following LSDs: Fabry (51), Gaucher Type I (6), mucopolysaccharidosis Type I (2), mucopolysaccharidosis Type II (2), mucopolysaccharidosis Type III (7), metachromatic leukodystrophy (3), and mucopolysaccharidosis Type IV (2). None of these patients are currently ventilated.…”